Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Filings indexed 445 across all filing types
Latest filing 2022-12-31 Regulatory Filings
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
This is to inform that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, Trading Window for dealing in Securities of the Company will remain closed for all Directors, ....
Regulatory Filings
2022-12-31 English
Newspaper Clipping of Notice of Extra Ordinary General Meeting (EGM) of the company published in English and Hindi language newspaper
Regulatory Filings
2022-12-27 English
Audit Committee, NOMINATION & REMUNERATION COMMITTEE and STAKEHOLDERS RELATIONSHIP COMMITTEE be and is hereby reconstituted
Regulatory Filings
2022-12-27 English
Consent of the board of directors of the company be and is hereby accorded to open a corporate office of the company at 304, 3rd Floor, Babukhan Estates, Basheerbagh, Hyderabad 500001 Telangana IN.
Regulatory Filings
2022-12-27 English
Brief profile of CEO and COO who were appointed in Board Meeting held on 23rd December, 2022
Regulatory Filings
2022-12-27 English
1. Extra-Ordinary General Meeting of the Company will be held on Thursday, 19th Jaunuary, 2023 at 11:00 A.M at the corporate office of the company at 304, 3rd Floor, Babukhan Estates, ....
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal notification addressed to the stock exchange about the scheduling of an Extra-Ordinary General Meeting (EGM), including details on the meeting date, cut-off date for voting eligibility, and remote e-voting period. It does not contain any financial data, results, or detailed reports but is an announcement related to the meeting logistics and voting process. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly a meeting notice. However, since it is specifically about the EGM and voting arrangements, it aligns best with the DVA category which covers official results and voting rights announcements. The document length is short and it is not a report itself but an announcement related to shareholder voting rights and meeting details.
2022-12-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.